Evidence map›Paper›PMID 38435425›Full record

ArticleHemaSphere2024

Analysis of immunoglobulin/T-cell receptor repertoires by high-throughput RNA sequencing reveals a continuous dynamic of positive clonal selection in follicular lymphoma.

Victor Bobée, Mathieu Viennot, Vinciane Rainville, Liana Veresezan, Fanny Drieux, Pierre-Julien Viailly, Victor Michel, Vincent Sater, Marie-Delphine Lanic, Elodie Bohers and 4 more

Open access · goldAbstract read
In one paragraph

Article in HemaSphere, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 1 institution in 1 country.

Victor BobéeINSERM U1245, Centre Henri Becquerel, UNIROUEN University of Normandie Rouen France.ORCID 0000-0002-9357-4542
Mathieu ViennotINSERM U1245, Centre Henri Becquerel, UNIROUEN University of Normandie Rouen France.
Vinciane RainvilleINSERM U1245, Centre Henri Becquerel, UNIROUEN University of Normandie Rouen France.
Liana VeresezanINSERM U1245, Centre Henri Becquerel, UNIROUEN University of Normandie Rouen France.
Fanny DrieuxINSERM U1245, Centre Henri Becquerel, UNIROUEN University of Normandie Rouen France.
Pierre-Julien ViaillyINSERM U1245, Centre Henri Becquerel, UNIROUEN University of Normandie Rouen France.
Victor MichelINSERM U1245, Centre Henri Becquerel, UNIROUEN University of Normandie Rouen France.
Vincent SaterINSERM U1245, Centre Henri Becquerel, UNIROUEN University of Normandie Rouen France.
Marie-Delphine LanicINSERM U1245, Centre Henri Becquerel, UNIROUEN University of Normandie Rouen France.
Elodie BohersINSERM U1245, Centre Henri Becquerel, UNIROUEN University of Normandie Rouen France.
Vincent CamusINSERM U1245, Centre Henri Becquerel, UNIROUEN University of Normandie Rouen France.
Hervé TillyINSERM U1245, Centre Henri Becquerel, UNIROUEN University of Normandie Rouen France.
Fabrice JardinINSERM U1245, Centre Henri Becquerel, UNIROUEN University of Normandie Rouen France.
Philippe RuminyINSERM U1245, Centre Henri Becquerel, UNIROUEN University of Normandie Rouen France.
Inserm · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Follicular lymphoma (FL) course is highly variable, making its clinical management challenging. In this incurable and recurring pathology, the interval between relapses tends to decrease while aggressiveness increases, sometimes resulting in the transformation to higher-grade lymphoma. These evolutions are particularly difficult to anticipate, resulting from complex clonal evolutions where multiple subclones compete and thrive due to their capacity to proliferate and resist therapies. Here, to apprehend further these processes, we used a high-throughput RNA sequencing approach to address simultaneously the B-cell immunoglobulin repertoires and T-cell immunoglobulin repertoires repertoires of lymphoma cells and their lymphoid microenvironment in a large cohort of 131 FL1/2-3A patients. Our data confirm the existence of a high degree of intra-clonal heterogeneity in this pathology, resulting from ongoing somatic hyper-mutation and class switch recombination. Through the evaluation of the Simpson ecological-diversity index, we show that the contribution of the cancerous cells increases during the course of the disease to the detriment of the reactive compartment, a phenomenon accompanied by a concomitant decrease in the diversity of the tumoral population. Clonal evolution in FL thus contrasts with many tumors, where clonal heterogeneity steadily increases over time and participates in treatment evasion. In this pathology, the selection of lymphoma subclones with proliferative advantages progressively outweighs clonal diversification, ultimately leading in extreme cases to transformation to high-grade lymphoma resulting from the rapid emergence of homogeneous subpopulations.

Identifiers

PMID38435425
PMCPMC10896008
OpenAlexW4392170188

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.